ArticlePloS one2025
Multi-perspective analysis of skin microbiota in elderly eczema patients.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eczema is a common inflammatory skin disease in elderly people. It not only causes physical damage to elderly people but also seriously affects their mental health. The skin microbiota plays a vital role in the development of skin disease. However, relatively few studies have investigated the characteristics of the skin microbiota in elderly eczema patients. In this study, the differences in the composition of the skin microbiota between lesion sites and healthy sites, between exposed sites and unexposed sites, and between elderly and younger eczema sites were analyzed, aiming to characterize the skin microbiota in elderly eczema patients from multiple perspectives and provide a basis for clinical diagnosis and treatment. The results indicated that the species richness of elderly eczema patients was greater than that of younger eczema patients. There was no significant difference between groups at the phylum level. At the genus level, the abundance of Staphylococcus significantly increased in the lesion sites of the elderly group. Compared with the younger eczema group, the elderly eczema group had greater abundances of Paracoccus, Deinococcus_B, Kaistella, Escherichia_710834, and Chryseobacterium_796703. These findings indicated that more attention should be given to the roles of Kaistella and Streptococcus in elderly eczema patients because Kaistella was the only genus among the 20 most abundant genera that was closely related to the EASI scores. Moreover, correlation analysis suggested that many genera had a positive relationship with Streptococcus. The results provide basic microbiological data for physicians treating elderly patients with eczema.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.